Skip to content
Thursday, June 04, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Hezbollah rejects US-brokered ceasefire deal struck by Lebanon and Israel June 4, 2026
  • Holocaust Museum LA Unveils Major Expansion for Future Generations June 3, 2026
  • Jewish Agency’s Israeli Emissaries from the U.S. March in New York’s Israel Day Parade June 2, 2026
  • Finalists announced for lucrative Jewish literary award June 2, 2026
  • ‘Canada’s civic compact is failing Jewish Canadians,’ Carney says as he unveils effort to address antisemitism June 1, 2026
  • Trump says Netanyahu ‘turned his Troops around’ after he asked Israel not to bomb Beirut June 1, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.